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ABSTRACT
The MADS-box transcription factor Mcm1p and fork-
head (FKH) transcription factor Fkh2p act in a DNA-
bound complex to regulate cell-cycle dependent
expression of the CLB2 cluster in Saccharomyces
cerevisiae. Binding of Fkh2p requires prior binding
by Mcm1p. Here we have investigated the molecular
determinants governing the formation of the Mcm1p±
Fkh2p complex. Fkh2p exhibits cooperativity in com-
plex formation with Mcm1p and we have mapped a
small region of Fkh2p located immediately upstream
of the FKH DNA binding domain that is required for
this cooperativity. This region is lacking in the
related protein Fkh1p that cannot form ternary com-
plexes with Mcm1p. A second region is identi®ed
that inhibits Mcm1p-independent DNA binding by
Fkh2p. The spacing between the Mcm1p and Fkh2p
binding sites is also a critical determinant for com-
plex formation. We also show that Fkh2p can form
ternary complexes with the human counterpart of
Mcm1p, serum response factor (SRF). Mutations at
analogous positions in Mcm1p, which are known to
affect SRF interaction with its partner protein Elk-1,
abrogate complex formation with Fkh2p, demonstrat-
ing evolutionary conservation of coregulatory
protein binding surfaces. Our data therefore provide
molecular insights into the mechanisms of Mcm1p±
Fkh2p complex formation and more generally aid our
understanding of MADS-box protein function.
INTRODUCTION
The transcription factor Mcm1p regulates several diverse
processes including mating type determination, arginine
metabolism and cell-cycle control in Saccharomyces cere-
visiae (reviewed in 1,2). In each case, Mcm1p recruits distinct
coregulatory proteins to promoters to enable speci®c
responses to be elicited. During the cell cycle, Mcm1p
controls the expression of early cell-cycle box-regulated genes
at the M/G1 phase boundary (3) and the expression of the
CLB2 cluster in the G2 and M phases (4), where it functions in
a complex with the forkhead (FKH) transcription factor,
Fkh2p (reviewed in 5) (6±9). Fkh2p cooperatively binds with
Mcm1p to form swi ®ve factor (SFF) complexes on the
promoters of genes in the CLB2 cluster including SWI5 (8,10).
In contrast, the related transcription factor Fkh1p does not
appear to form part of the SFF complex that forms on the SWI5
promoter or exhibit binding cooperativity with Mcm1p (8,10),
suggesting a speci®c role for Fkh2p in regulating gene
expression through these complexes. The Mcm1p±Fkh2p
complex activates transcription in the G2 and M phases of the
cell cycle in conjunction with the coactivator Ndd1p (6) and,
along with Fkh1p, appears to play a repressive role on target
genes during the rest of the cell cycle (8).
The Mcm1p±Fkh2p complex exhibits several similarities
with the mammalian Elk-1±serum response factor (SRF)
complex. The Elk-1±SRF complex is also thought to play a
role in cell-cycle control but acts to regulate cell-cycle entry in
response to mitogenic signalling (reviewed in 11,12).
Together with SAP-1 and SAP-2, Elk-1 constitutes part of
the ternary complex factor (TCF) subfamily of ETS-domain
proteins. Like FKH transcription factors, ETS-domain
proteins contain a winged helix±turn±helix DNA binding
domain. SRF andMcm1p are both members of the MADS-box
family of transcription factors and their core DNA binding
domains are 70% identical (reviewed in 2). This similarity is
emphasised by their related DNA binding speci®cities and the
abilities of Mcm1p and SRF to interact with several of their
respective binding partners (13±15). In addition to protein±
DNA contacts, protein±protein interactions are essential for
the formation of the Elk-1±SRF complex. Structural and
mutagenic studies on the related Elk-1±SRF and SAP-1±SRF
complexes have identi®ed the reciprocal interaction surfaces
in these transcription factors (14,16±18). A key feature of this
interaction is the insertion of an aromatic residue in the TCF
component into a hydrophobic pocket on the surface of SRF.
The analogous pocket on the surface of Mcm1p is used to bind
to the coregulatory protein MATa2 (19).
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In this study, we have investigated the molecular determin-
ants required for the formation of the Mcm1p±Fkh2p complex.
We show that the spacing of the Fkh2p and Mcm1p binding
sites is important for permitting complex function. Moreover,
Fkh2p contains an autoinhibitory domain that stops autono-
mous DNA binding in the absence of Mcm1p and a second
motif that is required for cooperative DNA binding with
Mcm1p. Upon disruption of the reciprocal binding pocket on
Mcm1p, Fkh2p binding is abrogated. Mcm1p is essential for
viability and versions containing mutations of the Fkh2p
binding pocket cannot rescue a deletion of the MCM1 gene.
Similarly, a mutation in the Mcm1p binding motif of Fkh2p
affects Fkh2p activity in vivo. The molecular determinants of
Mcm1p±Fkh2p complex formation therefore show several
parallels with the Elk-1±SRF complex although important
differences also exist.
MATERIALS AND METHODS
Plasmid constructions and mutagenesis
The pBluescript-KS+-derived plasmids, pAS1 (encoding coreSRF;
amino acids 132±222), pAS37 (encoding METcoreSRF; amino
acids 142±222) (20), and pAS704 (encoding coreMcm1; amino
acids 1±98) (21) and pAS798 (22) have been described
previously.
The following plasmids were created for in vitro transcrip-
tion/translation. CoreMcm1 mutants: plasmids encoding single
point mutants, pAS1611 (T71A), pAS1612 (T82E), pAS1613
(V69E) and pAS1128 (T71E), were constructed using frag-
ments obtained from a two-step PCR protocol (23) with two
¯anking primers FOR and REVL, the template pAS704 and
the mutagenic primers ADS941, ADS944, ADS943 and
ADS983, respectively. PCR products were cleaved with
XbaI and either NcoI or HindIII and ligated into pAS37
derivatives cleaved with the same enzymes. pAS1607 and
pAS1608 (encoding Fkh1p amino acids 227±421 and
287±421, respectively) were constructed by inserting NcoI/
XhoI-cleaved PCR fragments (generated using primers
ADS906/908 and ADS907/908, respectively, and yeast
genomic DNA as a template) into the same sites in pAS798.
pAS1241 [encoding Fkh2(458±862)], pAS1243 [encoding
Fkh2(1±458)], pAS1244 [encoding Fkh2(180±458)],
pAS1246 [encoding Fkh2(216±458)], pAS1247 [encoding
Fkh2(254±458)], pAS1248 [encoding Fkh2(292±458)],
pAS1249 [encoding Fkh2(325±458)], pAS1830 [encoding
Fkh2(302±458)] and pAS1829 [encoding Fkh2(312±458)]
were constructed by inserting NcoI/XhoI-cleaved PCR frag-
ments (generated using primers ADS863/862, ADS857/871,
ADS870/871, ADS877/871, ADS878/871, ADS879/871,
ADS880/871, ADS1003/871 and ADS1004/871, respectively)
into the same sites in pAS798. pAS1242 [encoding
Fkh2(1±862)], was constructed by inserting a NcoI-cleaved
PCR fragment (generated using primers ADS857/858, on
yeast genomic DNA) into NcoI-cleaved pAS1241. pAS1764
encoding Fkh2(292±458)(Y315E) was constructed using
fragments obtained from a two-step PCR protocol (23) with
two ¯anking primers ADS879 and REVL, the template
pAS1247 and the mutagenic primer ADS1905. The PCR
product was cleaved with NcoI and XhoI and ligated into
pGBKT7 (Clontech) cleaved with NcoI and SalI.
The following bacterial expression vectors were created:
pAS1752 (encoding Fkh2p amino acids 254±458 fused to
GST) was constructed by inserting a EcoRI/XhoI-cleaved PCR
fragment into the same sites in pGEXKG (24). pAS799
[encoding Mcm1p amino acids 1±96 fused to maltose binding
protein (MBP)] was kindly provided by Cynthia Wolberger.
The following yeast expression vectors were created:
pMW20-NDD1 (URA3 CEN/ARS) was created by ligating a
BamHI-digested PCR fragment carrying the full-length NDD1
gene into the same site in pMW20 (kindly provided by
M. Walberg). pAS797 [Mcm1 amino acids 1±98; aka
pSL2190 (25); Mcm1(1±98) under the control of the MCM1
upstream promoter region in vector pRS314, a CEN/ARS-
TRP1 yeast shuttle vector]. pAS1768, encoding the V69E
mutant Mcm1p clone was created by replacing the EcoRI/
BglII fragment from pAS797 with an identically cleaved PCR
fragment from pAS1613. pAS1762 (encoding a GAL4 DNA
binding domain fusion to Fkh2p amino acids 1±458) was
created by inserting a NcoI/EcoRI-cleaved PCR fragment into
the same sites in pAS1241. pAS1767 (encoding a GAL4 DNA
binding domain fusion to the Y315E mutant of Fkh2p amino
acids 1±458) was created using a two-step PCR protocol (23)
on the template pAS1242 using the mutagenic primer
ADS1905. The PCR product was cleaved with NcoI and
XhoI and ligated into pGBKT7 (Clontech) cleaved with NcoI
and SalI.
Details of PCR primers can be supplied upon request. The
sequences of all plasmids encoding mutant proteins and PCR-
derived sequences were con®rmed by automated dideoxy
sequencing.
Protein production and pulldown assays
Wild-type and mutant Mcm1p proteins (using wheat germ
lysates, Promega), SRF (using rabbit reticulocyte lysates,
Promega) and Fkh2p derivatives (using wheat germ or rabbit
reticulocyte lysates, Promega) were produced by coupled or
sequential in vitro transcription and translation and subse-
quently analysed and quanti®ed as described previously (26).
MBP±Mcm1(1±96) fusion proteins were puri®ed as described
previously (27) and the Mcm1p moiety released by factor Xa
cleavage. GST fusion proteins were prepared and pulldown
assays were carried out as described previously (28) using
GST±Fkh2(254±458) and in vitro translated Mcm1p
derivatives.
Gel retardation analysis
Gel retardation assays on the SWI5 site were carried out
essentially as described previously (8) or the indicated
derivatives (see Fig. 5A). All sites had CTAG overhangs at
their 5¢ ends for labelling with Klenow. The following sources
of protein were used: bacterially-expressed Mcm1p (Figs 3
and 5), in vitro translated Mcm1p (wheat germ lysate, Figs 1,
2, 4 and 6), in vitro translated Fkh2p (wheat germ lysate, Figs 3
and 5; rabbit reticulocyte lysate, Figs 1, 2, 4 and 6).
Yeast strains, growth conditions and 5-¯uoroorotic acid
(5-FOA) selection
Yeast strains used were: YY2052 [MATa P(PAL)-lacZ::fus1/
pSL1574], where pSL1574 is a plasmid that contains MCM1
on a CEN/ARS-URA3 vector (25), AP173 (a/a ade± leu2 trp1
his3 ura3 FKH2/fkh2::URA3 NDD1/ndd1::HIS3); AP175 (a/a
2280 Nucleic Acids Research, 2003, Vol. 31, No. 9
 at U
n
iv
ersity
 o
f N
ew
castle o
n
 F
eb
ru
ary
 8
, 2
0
1
2
h
ttp
://n
ar.o
x
fo
rd
jo
u
rn
als.o
rg
/
D
o
w
n
lo
ad
ed
 fro
m
 
ade± leu2 trp1 his3 ura3 FKH2/fkh2::LEU2 NDD1/ndd1::
HIS3) and AP183 (a ade± leu2 trp1 his3 ura3 fkh2::LEU2
ndd1::HIS3). To construct a fkh2Dndd1D haploid strain, one
copy of the NDD1 gene was replaced by the HIS3 gene, and
the URA3 selectable marker disrupting one copy of the FKH2
gene in AP173, was replaced by the LEU2 gene, to create
AP175. The HIS3 and LEU2 cassettes were ampli®ed from
YDp-HIS and YDp-LEU (29) by PCR using the Ndd1delfow/
Ndd1delrev and F2-1/F2-2 oligonucleotide primers, respect-
ively. Gene replacements were con®rmed by PCR. The
fkh2Dndd1D haploid strain, AP183, was isolated following
sporulation of the AP175 diploid containing pMW20-NDD1.
Details of primers can be provided on request.
Yeast strains were grown at 30°C in rich (YPD) or minimal
(SD) media (28). Sporulation medium was 1% potassium
acetate, 0.1% yeast extract, 0.05% dextrose and 2% agar (27).
Yeast cells were transformed using the lithium acetate method
(30).
FOA selection was used to select for cells that could lose
pMW20-NDD1 (in a fkh2D background) and pSL1574 (in a
mcm1D background). The fkh2Dndd1D haploid strain, AP183,
was co-transformed with pMW20-NDD1 and either pGBKT7
(vector), pGBKT7-Fkh2(1±458) or pGBKT7-Fkh2(1±458)
(Y315E). YY2052 was transformed with pAS797 or
pAS1768. Equal numbers of cells from 20 colonies of each
transformation were re-suspended in 1 ml of water. Ten-fold
serial dilutions (neat, 1/10, 1/100, 1/1000) were then spotted
onto SD plates or plates containing 5-FOA and the appropriate
supplements. Plates were incubated at 30°C for 2±5 days to
kill cells containing the URA3 gene (31).
Figure generation
All ®gures were generated electronically from either phos-
phorimager ®les (Bio-Rad Quantity One software) or scanned
autoradiographic images using Adobe PhotoDeluxe (Adobe)
and PowerPoint (Microsoft) software. Final images are
representative of the original autoradiographic images.
RESULTS
Identi®cation of regions of Fkh2p involved in
cooperative Mcm1p±Fkh2p complex formation
Fkh2p forms ternary complexes with Mcm1p on the promoters
of genes in the CLB2 gene cluster such as SWI5 (Fig. 1A)
(6±9). To establish whether Fkh2p requires Mcm1p to bind to
the SWI5 promoter, we carried out gel retardation analysis
with a fragment of the SWI5 promoter and in vitro translated
Mcm1(1±98) and full-length Fkh2(1±862) proteins (Fig. 1B).
Whilst Mcm1p binds in the absence of Fkh2p, Fkh2p binding
is absolutely dependent on the presence of Mcm1p (Fig. 1B,
lanes 1 and 3). This is indicative of cooperative binding, and is
consistent with other recent observations (10).
A series of truncated Fkh2p proteins was created to map the
regions required for ternary complex formation with Mcm1p
(Fig. 2A). These proteins were tested for DNA binding in the
presence (Fig. 2B, lanes 1±8) or absence (Fig. 2B, lanes 9±16)
of Mcm1p. Ternary complex formation was still observed
upon deletion of the C-terminus (amino acids 458±862) of
Fkh2p (Fig. 2B, lane 3), and was retained upon further
N-terminal deletion to amino acid 292 (Fig. 2B, lane 7).
However, ternary complex formation was lost upon further
N-terminal truncation to amino acid 325 (Fig. 2B, lane 8).
Unexpectedly, the formation of stable ternary complexes was
lost in the Fkh2(180±458) and Fkh2(216±458) constructs
(Fig. 2B, lanes 4 and 5) although the band smearing in these
lanes is indicative of complex breakdown during electro-
phoresis (see Discussion). We did not expect the Fkh2p
truncations to bind to the SWI5 site in the absence of Mcm1p
and indeed this was the case upon N-terminal deletion to
amino acid 254 (Fig. 2B, lanes 9±14). However, upon
N-terminal truncation to amino acid 292, autonomous DNA
binding by Fkh2p was revealed (Fig. 2B, lane 15). Thus,
sequences located between amino acids 254 and 292 act to
inhibit autonomous DNA binding by Fkh2p.
Previously we proposed that the Mcm1p±Fkh2p complex
might be functionally analogous to the human Elk-1±SRF
complex (8). The Mcm1p and SRF core DNA binding
domains exhibit a high degree of sequence similarity and
related DNA binding speci®cities (70% identity) (15), hence
we next tested whether coreSRF (amino acids 132±222) could
interact with Fkh2p on the SWI5 site (Fig. 2C). As observed
with Mcm1p, ternary complex formation with SRF was
identi®able upon C- and N-terminal deletion of Fkh2p to
amino acids 292±458. However, unlike Mcm1p±Fkh2p
ternary complexes, ternary complexes between either
Fkh2(216±458) or Fkh2(254±458) and SRF did not undergo
dissociation during electrophoresis, suggesting a more stable
interaction. However, the binding of longer Fkh2 derivatives
was reduced compared with Fkh2(254±458), suggesting a
possible role for additional inhibitory regions in this context.
To further delineate the minimal part of Fkh2p that could
form ternary complexes with Mcm1p, an additional series of
Figure 1. Fkh2p requires Mcm1p to bind the SWI5 promoter. (A) Schematic
of the ternary Mcm1p±Fkh2p complex that forms on the composite
CArG±Fkh binding motif in the SWI5 promoter. (B) Gel retardation analysis
of in vitro translated Mcm1(1±98) and full-length Fkh2p on the CArG±fkh
motif from the SWI5 promoter. The addition of Fkh2p and Mcm1p, and the
locations of the DNA-bound Mcm1p and Mcm1p±Fkh2p complexes are
indicated. The asterisk represents a non-speci®c band arising from the
reticulocyte lysates.
Nucleic Acids Research, 2003, Vol. 31, No. 9 2281
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N-terminal truncations was made (Fig. 3A). In this series of
experiments, Mcm1(1±96) was used. DNA binding by the
Fkh2p derivatives was similar in the absence of Mcm1p
(Fig. 3B, lanes 1±4). However, ternary complex formation was
reduced upon truncation beyond amino acid 312 (Fig. 3B,
lanes 5±8). To further investigate this cooperativity, DNA
binding was tested using titrations of Fkh2(312±458) and
Fkh2(325±458) and DNA binding tested in the presence or
absence of Mcm1p. Cooperativity in ternary complex form-
ation was observed using Fkh2(312±458) but greatly reduced
upon N-terminal truncation to amino acid 325 (Fig. 3C and D).
Thus these data demonstrate that sequences located between
amino acids 312 and 325 are essential for cooperative ternary
complex formation with Mcm1p.
To identify important residues within this region, we carried
out site-directed mutagenesis experiments (Fig. 3E and F). We
speci®cally targeted aromatic residues in this region as these
had previously been shown to be important for the binding of
coregulatory proteins to other MADS-box proteins (16,17,19).
Indeed alignment of amino acids 213±333 from Fkh2p with
the B-box SRF binding region of Elk-1 shows a potential
conservation of several such residues (Fig. 3E). Mutation of
amino acid Y315 in Fkh2p had little effect on its Mcm1p-
independent DNA binding capacity (Fig. 3F, lane 2), but
abolished cooperative binding with Mcm1p (Fig. 3F, lane 5).
In contrast, mutation of either Y321 or F324 had little effect
on ternary complex formation with Mcm1p (data not shown).
Collectively, our truncation studies have identi®ed
Mcm1(1±96) and Fkh2(312±458) as minimal determinants
for the cooperative formation of Mcm1p±Fkh2p ternary DNA-
bound complexes. Y325 has been shown to be a key amino
acid in Fkh2 that is required for the formation of these
complexes.
Cooperative ternary complex formation is not observed
with Fkh1p
Previously we demonstrated that Fkh1p does not constitute a
major part of the ternary complex that forms on the SWI5
promoter in yeast cell extracts (8). However, the regions
encompassing the FKH DNA binding domains of Fkh1p and
Fkh2p are very similar in sequence (72% identity through
amino acids 329±454 of Fkh2p). However, this sequence
similarity diverges in the region immediately upstream from
the FKH domain that we have shown to be important for the
Figure 2. Mapping the ternary complex determinants in Fkh2p. (A) A schematic of the truncated Fkh2p constructs generated for the mapping analysis. The
locations of the FHA and FKH domains are indicated. The minimal region required for ternary complex formation and the location of the autoinhibitory
domain are indicated. The dotted line indicates that the C-terminal end of the autoinhibitory motif is unknown. The ability of each Fkh2p construct to form
ternary complexes and exhibit autoinhibitory DNA binding properties is indicated. (B and C) Gel retardation analysis of the indicated Fkh2p proteins in the
presence or absence of Mcm1(1±98) (B) or in the presence of SRF(132±222) on the P(SWI5) site. Asterisks indicate Fkh2p truncations that bind DNA in the
absence of Mcm1p.
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formation of Mcm1p±Fkh2p complexes (Fig. 3A). We
therefore compared analogously truncated Fkh1p and Fkh2p
proteins for their ability to form ternary complexes with
Mcm1p on the SWI5 promoter (Fig. 4).
Fkh2(254±458) ef®ciently formed ternary complexes with
Mcm1p (Fig. 4B, lane 7) but the analogous Fkh1p
construct, Fkh1(227±421) was unable to ef®ciently form
ternary complexes (Fig. 4B, lane 5). The FKH domains of both
proteins bind autonomously to the SWI5 site, albeit at a lower
ef®ciency with Fkh1p (Fig. 4B, lanes 2 and 4). Thus,
Fkh1p exhibits a lower intrinsic binding propensity for the
SWI5 promoter and moreover, unlike Fkh2p, is unable to
cooperatively form ternary complexes with Mcm1p.
Binding site spacing requirements for the formation of
Mcm1p±Fkh2p complexes
The DNA binding sites in the Mcm1p±Fkh2p complex are
closely juxtaposed (Fig. 5A) (8). Furthermore, our mapping
data have identi®ed a motif that is required for cooperative
interactions with Mcm1p that is located close to the Fkh2p
DNA binding domain (Fig. 3). This motif is likely to represent
the Mcm1p interacting region of Fkh2p. In the SRF±Elk-1
complex, the spacing between the DNA binding sites can be
highly variable (32). We therefore tested the spacing require-
ments of the Fkh2p and Mcm1p binding sites, which permit
ef®cient complex formation. A series of binding sites was
Figure 3. Fine mapping of the Fkh2p `cooperativity domain'. (A) A schematic of the truncated Fkh2(292±458) protein. The amino acid sequence of the
sequence immediately preceding the FKH domain of Fkh2p and the analogous region in Fkh1p are shown. The amino acids at the truncation endpoints are
highlighted. (B) Gel retardation analysis of the indicated Fkh2p truncated proteins in the absence (lanes 1±4) or presence (lanes 5±8) of Mcm1(1±96) on the
P(SWI5) site. (C) Gel retardation analysis of increasing amounts of the truncated Fkh2p truncated proteins in the presence (lanes 1±10) or absence
(lanes 11±20) of Mcm1(1±96). Relative molar amounts of Fkh2p were 1 (lanes 1, 6, 11 and 16); 3 (lanes 2, 7, 12, 17); 5 (lanes 3, 8, 13, 18); 10 (lanes 4, 9,
14, 19); 20 (lanes 5, 10, 15, 20). (D) Quanti®cation of the data in (C). The binding observed with the highest concentrations of Fkh2p used is not shown as
the binding in lane 5 is beyond the linear range. (E) Alignment of amino acids 312±333 of Fkh2p with the B-box region (amino acids 150±168) of Elk-1.
Amino acids in Elk-1 that affect interactions with SRF by >50% (18) are shaded. These are conserved in Fkh2p. (F) Gel retardation analysis of the indicated
Fkh2p mutant proteins in the absence (lanes 1±3) or presence (lanes 4±6) of Mcm1(1±96) on the P(SWI5) site.
Nucleic Acids Research, 2003, Vol. 31, No. 9 2283
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created in which nucleotides were either added or removed
from the spacer region located between the core Fkh2p and
Mcm1p binding sites (Fig. 5A).
The insertion of 2 or 5 bp between Fkh2p and Mcm1p
binding sites led to a large decrease in ternary complex
formation (Fig. 5B, lanes 2 and 3). However, the addition of
10 bp (corresponding to one helical turn) restored ternary
complex formation, albeit to a reduced level in comparison to
the wild-type spacing (Fig. 5B, lane 1). The deletion of either
1 or 3 bp between the two binding sites also caused a large
decrease in the ef®ciency of Mcm1p±Fkh2p complex forma-
tion (Fig. 5B, lanes 5 and 6). To ensure that the changes we
had introduced did not affect protein±DNA interactions
mediated by the FKH domain of Fkh2p, we tested the ability
of Fkh2(325±458) to bind to each of the sites (Fig. 5C).
Binding of Fkh2(325±458) to all the sites was readily
detectable, in contrast to the large decreases observed in the
context of ternary complexes. We also tested the requirement
for binding site orientation by inverting the asymmetric Fkh2p
binding site (Fig. 5D). Inversion of the binding site resulted in
abrogation of complex formation (Fig. 5E, lane 4) but still
allowed autonomous binding of the Fkh2p FKH DNA binding
domain (Fig. 5F, lanes 1 and 2).
Collectively these data demonstrate the critical importance
of binding site spacing and orientation for the ef®cient
formation of DNA-bound Mcm1p±Fkh2p ternary complexes.
Identi®cation of Fkh2p interaction determinants on
Mcm1p
The observation that Fkh2p can form ternary complexes with
both Mcm1p and its mammalian counterpart SRF (Fig. 2B and
Figure 4. Fkh1p does not bind cooperatively with Mcm1p. (A) Schematic
of full-length and truncated versions of Fkh1p and Fkh2p. (B) Gel retard-
ation analysis of the indicated Fkh1p and Fkh2p truncated proteins in the
absence (lanes 1±4) or presence (lanes 5±8) of Mcm1(1±98) on the
P(SW15) site. The locations of complexes corresponding to Mcm1p alone,
Fkh1p/Fkh2p alone or Mcm1p±Fkh2p complexes are indicated. The asterisk
indicates the location of a band corresponding to a weak ternary complex.
Figure 5. In¯uence of binding site spacing on Mcm1p±Fkh2p complex
formation. (A) Schematic of the Mcm1p±Fkh2p ternary complex bound to
the P(SWI5) site. The sequence of the wild-type site and `spacer' mutants
are shown below. The fkh binding motif is shown in bold and underlined
and the CArG box Mcm1p binding motif is boxed. (B and C) Gel retard-
ation analysis of Fkh2(1±862) (B) and Fkh2(325±458) (C) in the presence
(B) or absence (C) of Mcm1(1±96) bound to the indicated wild-type (WT)
and `spacer' mutant binding sites. (D) Schematic of the Mcm1p±Fkh2p
complex and the P(SW15)Rev binding site. The arrows represent the rela-
tive orientation of the Mcm1p and Fkh2p binding sites. (E and F) Gel
retardation analysis of Fkh2(1±862) (E) and Fkh2(325±458) (F) in the pres-
ence (E) and absence (F) of Mcm1p on the WT and Rev versions of the
P(SWI5) site. The locations of Mcm1p, Fkh2p and Mcm1p±Fkh2p
complexes are indicated in each panel.
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C) indicates that the binding surface on Mcm1p and SRF is
likely to be conserved. To explore this further, a series of
mutant SRF derivatives was examined for binding ability to
Fkh2p on the SWI5 promoter. One of these mutants, V194E,
abolished ternary complex formation (data not shown).
Previously, this mutation was shown to also abolish Elk-1
binding to SRF (18). Predictions from structural studies
suggest that this mutation would block the insertion of
aromatic residues into a binding pocket on the surface of
Mcm1p (16). Indeed, we have identi®ed Y315 as a residue that
has a critical role in mediating ternary complex formation
between Fkh2p and Mcm1p (Fig. 3F). To establish whether
the equivalent residue in Mcm1p was also important for Fkh2p
interactions, a Mcm1(1±98) mutant protein was constructed
containing the V69E mutation. In addition, several additional
mutants were obtained at T71 (T71A, T71E), which are known
to be important for SRF interactions with its coregulatory
partner, Elk-1 (Fig. 6A) (18). The T82E mutant Mcm1p
protein was used as a negative control that is predicted not to
effect ternary complex formation based on the SRF±Elk-1
paradigm (18). The locations of these residues on the surface
of Mcm1p are shown in Figure 6B.
Ternary complex formation between Mcm1(1±98)(V69E)
and full-length Fkh2p was virtually abolished (Fig. 6C, lane 7).
In contrast, the introduction of the T71E mutation only had a
moderate effect on ternary complex formation, while T71A
actually exhibited enhanced binding (Fig. 6C, lanes 8 and 9;
see Discussion). The T82E mutation did not affect ternary
complex formation as predicted. Similar results were obtained
in the presence of the truncated Fkh2(254±458) (Fig. 6D),
demonstrating the importance of this region of Mcm1p in
binding to the interaction surface we have mapped in Fkh2p.
To examine whether the abrogation of ternary complex
formation between Mcm1(1±98)(V69E) and Fkh2p was due to
disruption of protein±protein interactions, we carried out GST
pulldown assays with GST±Fkh2(254±458) and wild-type and
mutant Mcm1p derivatives (Fig. 6E). The L68E mutant
version of Mcm1p was previously shown to disrupt DNA
bending and hence Mcm1p±Fkh2p complex formation but
does not disrupt protein±protein interactions with Fkh2p (33).
In comparison to wild-type and L68E mutant versions, the
V69E mutant exhibited much reduced binding to Fkh2p,
demonstrating that this mutation directly affects protein±
protein interactions between these two transcription factors.
Together, these results identify the pocket surrounding V69
in Mcm1p (see Fig. 6B) as a critical component of the
Mcm1p±Fkh2p interface. This same pocket is also important
for SRF±Fkh2p and SRF±Elk-1 interactions, demonstrating
an evolutionary conservation of this pocket for driving
cooperative ternary complex formation.
The effect of ternary complex disrupting mutations
in vivo
We have identi®ed mutations in both Mcm1p (V69E) and
Fkh2p (Y315E) that disrupt ternary complex formation. To
assess the importance of these residues, we next examined
Figure 6. Identi®cation of the Fkh2p binding surface on Mcm1p. (A) Alignment of the Elk-1 binding regions in SRF with the equivalent region in Mcm1p.
Residues mutated in this study are highlighted. Dots between the two sequences indicate identical amino acids. Residues comprising secondary structural
elements are bracketed. (B) A structural representation of Mcm1p bound to DNA (monomers coloured in yellow and orange) (19). The residues mutated in
this study are shown in blue. (C and D) Gel retardation analysis of the indicated Mcm1(1±98) mutants in the absence (C and D, lanes 1±5) or the presence of
either Fkh2(1±862) (C, lanes 6±10) or Fkh2(254±458) (D, lanes 6±10) on the P(SWI5) site. The locations of complexes corresponding to Mcm1p alone or
Mcm1p±Fkh2p are indicated. The amount of binary Mcm1p complex was normalised to give equivalent binding. (E) A GST pulldown experiment of
GST±Fkh2(254±458) and the indicated in vitro translated Mcm1(1±98) mutants. Ten percent of input protein is shown. Quanti®cation of the data normalised
to input protein is shown below and compared with wild-type Mcm1p (taken as `100'). The average of three independent experiments is shown.
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whether the corresponding mutant alleles ofMCM1 and FKH2
affected the cellular function of these proteins.
Previous studies have demonstrated that the inviability of an
mcm1D mutant can be rescued by a truncated version of
Mcm1p containing only the minimal DNA binding domain
[Mcm1(1±98)] (34). Indeed, we were able to rescue the
lethality of an mcm1D mutant with a plasmid encoding
Mcm1(1±98) (Fig. 7A). However, in contrast, a plasmid
encoding Mcm1(1±98)(V69E) was unable to support growth
of the mcm1D mutant (Fig. 7A).
Previously, it has been shown that the lethality associated
with a deletion of the NDD1 gene (35) can be rescued by
deletion of the FKH2 gene (6). Hence, to examine the function
of mutations of Fkh2p we constructed a fkh2Dndd1D double
mutant strain (AP183) and co-transformed this strain with
pMW20-NDD1, a URA3 plasmid expressing the wild type
NDD1 gene, and either vector (pGBKT7) or a plasmid
expressing amino acids 1±458 of Fkh2p [pGBKT7
Fkh2(1±458)]. Transformants were then plated onto 5-FOA
medium to kill cells that were unable to lose theURA3 plasmid
pMW20-NDD1. As expected cells co-transformed with pKT7
were able to lose pMW20-NDD1 (Fig. 7B). In contrast, cells
co-transformed with pGBKT7 Fkh2(1±458) were unable to
grow on 5-FOA medium (Fig. 7B) suggesting that the
inviability of ndd1D cells cannot be reversed by removing
the C-terminal region of Fkh2p (amino acids 459±862). The
N-terminal region (amino acids 1±458) of Fkh2p contains the
FKH DNA binding domain and also contains the region of
Fkh2p required for ternary complex formation with Mcm1p.
Hence, to test whether ternary complex formation was linked
to the inviability of the ndd1D, fkh2Dndd1D cells containing
pGBKT7 Fkh2(1±458)(Y315E) and pMW20-NDD1 were
plated on to 5-FOA medium. In contrast to wild-type protein,
the Y315E substitution reversed the lethality associated with
the Fkh2(1±458) construct in this background (Fig. 7B). The
Y315E substitution blocks interactions with Mcm1p in vitro
suggesting that the inviability of ndd1D cells is linked to the
inability of Mcm1p±Fkh2p ternary complexes to activate
transcription of the CLB2 gene cluster in the absence of
Ndd1p. Importantly, these data demonstrate that Y315 of
Fkh2p is required for the function of this protein in vivo.
Taken together, our data reveal that mutations of Mcm1p
and Fkh2p that affect the activities of these proteins in vitro
also affect their in vivo function. Hence, our in vitro studies
of the Mcm1p±Fkh2p ternary complex provide important
insights into the function and activity of this complex in vivo.
DISCUSSION
The Mcm1p±Fkh2p complex plays a pivotal role in regulating
genes in the late G2 and M phases of the cell cycle in
S.cerevisiae (reviewed in 5; 6±9). Here we provide molecular
details of how this complex forms. Importantly, we identify
regions and critical residues in Mcm1p and Fkh2p required for
cooperative binding of Fkh2p to Mcm1p-occupied sites and
demonstrate the importance of optimal DNA binding site
spacing for complex formation to occur. The validity of these
conclusions is supported by the demonstration that mutations
of the regions identi®ed as important for the formation of
Mcm1p±Fkh2p complexes disrupt the activities of these
proteins in vivo (Fig. 7).
The mammalian TCF±SRF complex represents a paradigm
for understanding the basis for cooperative transcription factor
complex formation (reviewed in 11,12). In this complex, a
short region of the TCFs, the B-box, is presented on a ¯exible
tether and binds to a surface exposed groove on the surface of
SRF (16±18). These protein±protein interactions are essential
for the recruitment of the TCF component into this complex.
Due to the presence of the ¯exible tether, the spacing between
the SRF and the TCF DNA binding sites can vary by over one
helical turn with no discernable effect on ternary complex
formation (32). The Mcm1p±Fkh2p complex shows many
similarities with this complex. The sequences and structures of
the MADS-box DNA binding domains of Mcm1p and SRF are
highly conserved (19,36). Similarly, both the TCFs and Fkh2p
contain a winged helix±turn±helix DNA-binding domain.
Furthermore, both the TCF and Fkh2p binding sites are
asymmetric. Here we demonstrate that Mcm1p and SRF use
the same binding pocket on their surfaces to interact with
Fkh2p and TCF, respectively (de®ned by the V69E mutation)
(Fig. 6). The importance of this mutation is further under-
scored by the inability to rescue mcm1 deleted strains with
Mcm1(1±98)(V69E), although this lethality probably re¯ects
a loss of interaction with other coregulatory partners in
addition to Fkh2p. Sequences located outside the DNA
binding domain are required on both TCFs and Fkh2p to
promote cooperativity in complex formation (Figs 1±4). How-
ever, the Mcm1p±Fkh2p complex differs in several key
respects. Unlike in the TCFs, a long ¯exible linker does not
exist in Fkh2p and the motif required for Mcm1p binding is
closely juxtaposed to its DNA binding domain. This suggests
that the DNA binding sites must be closely positioned. Indeed,
this view is supported by our observation that alteration of the
distance between the Mcm1p and Fkh2p binding sites in the
SWI5 promoter strongly reduces recruitment of Fkh2p by
Mcm1p (Fig. 5). In agreement with these data, inspection of
the potential binding sites for Mcm1p±Fkh2p complexes in the
promoters of genes that are known to be regulated by this
complex, in conjunction with Ndd1p (37), shows little
variability of this spacing (Fig. 8). Interestingly, some binding
Figure 7. The role of Mcm1p±Fkh2p interactions in vivo. (A) The mcm1D
mutant strain, YY2052, was transformed with plasmids encoding wild-type
or V69E version of Mcm1(1±98) and plated on SD or FOA plates (to
remove the plasmid-borne mcm1 allele). (B) The fkh2Dndd1D double mutant
(AP183) was transformed with pMW20-NDD1 and either the pGBKT7
vector (control), pGBKT7±Fkh2(1±458) or pGBKT7±Fkh2(1±458)(Y315E)
plasmids. Neat and 10-fold serial dilutions of transformants were spotted
onto SD and FOA plates. Plates were incubated at 30°C for 2±5 days.
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is regained upon addition of a full helical turn between the
DNA binding sites. This suggests that contacts might be
regained through bending of the intervening DNA when the
proteins are located on the same side of the helix. Mcm1p is
known to induce signi®cant DNA bending and this might
facilitate complex formation between Mcm1p and Fkh2p
(19,38). Indeed, mutant Mcm1p proteins that are com-
promised in their DNA bending abilities exhibit reduced
recruitment of Fkh2p (33).
The sequence of the region in Fkh2p that is required for
cooperative binding of Fkh2p to Mcm1p shares some simi-
larity with the B-box motif of the Elk-1 (Fig. 3F). In particular,
the three critical aromatic residues in Elk-1 are conserved. The
®rst two of these show identical spacing and encompass a
conserved serine residue (Ser318 in Fkh2p) that also plays an
important role in Elk-1 interactions with SRF. Apart from
these amino acids, no other residues were identi®ed as critical
for complex formation between Elk-1 and SRF (17). Of the
amino acids tested, only Y315 appears critical in Fkh2p,
suggesting a difference in how the interactions mediated by
Fkh2p and Elk-1 take place. Presumably, in Fkh2p, other
interactions compensate for the lack of effect seen by mutation
of other positions, possibly due to direct contacts between the
MADS-box and the FKH domains themselves due to their
close juxtapositioning. By extrapolating from the SRF±SAP-1
structure, the most likely role of Y315 is in making contacts
with Mcm1p but also in determining and stabilising the
trajectory of the Fkh2p motif across the surface of Mcm1p
(16). In contrast, the increased binding of Fkh2p observed with
the T71A mutant of Mcm1p is reminiscent of the binding of
Fli-1 to the analogous SRF mutant (T196A) (18), suggesting
that the interaction surface on Mcm1p used by Fkh2p retains
characteristics from both TCF± and Fli-1±SRF interactions.
Thus while Fkh2p uses the binding surface on Mcm1p that is
analogous to that used by TCF and Fli-1 to bind to SRF, the
exact interactions are likely to differ. Structural studies are
required to de®ne this interface more precisely.
Our DNA binding studies also uncovered additional
regulatory activities acting on Fkh2p. In particular, deletion
analysis identi®ed an autoinhibitory domain that prevents the
binding of Fkh2p to DNA in the absence of Mcm1p (Fig. 2).
Similar domains are found in many transcription factors
(including mammalian TCFs) that act to block spurious DNA
binding in the absence of coregulatory partner proteins (39). In
addition, our data revealed that deletion of the ®rst 180 amino
acids of Fkh2p destabilises Mcm1p±Fkh2p ternary complexes
until further deletions of residues 180±254 are made. This is
not observed in complexes of Fkh2p with SRF, indicating that
SRF±Fkh2p complexes are likely to be stronger (Fig. 2). This
observation points to a potential role for the N-terminal part of
Fkh2p [that includes the FKH-associated (FHA) domain] in
stabilising Mcm1p±Fkh2p ternary complexes in combination
with amino acids 180±254. As FHA domains are often sites of
protein±protein interactions, this might have regulatory
implications for the complex. Finally, it should be noted that
the region of Fkh2p required for DNA binding cooperativity is
not conserved with Fkh1p (Fig. 4) and Fkh1p is incapable of
cooperatively forming ternary complexes with Mcm1p (Fig. 4)
(10). Thus, our results clearly de®ne in molecular terms why
the highly related transcription factors Fkh1p and Fkh2p
exhibit different propensities in forming complexes with
Mcm1p and hence divergent functions in vivo.
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